CONMED
CNMD
262 hedge funds and large institutions have $4.11B invested in CONMED in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 99 increasing their positions, 77 reducing their positions, and 26 closing their positions.
42% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 26
29% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 77
4% more funds holding
Funds holding: 252 → 262 (+10)
0.22% more ownership
Funds ownership: 107.96% → 108.17% (+0.22%)
4% less capital invested
Capital invested by funds: $4.3B → $4.11B (-$184M)
83% less call options, than puts
Call options by funds: $2.09M | Put options by funds: $12.7M
Top Buyers
Top Sellers
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
-$34.8M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$15.6M |
| 3 |
BlackRock
New York
|
-$15.6M |
| 4 |
DIG
DeepCurrents Investment Group
New York
|
-$13.8M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
-$10.8M |
CNMD Hedge Fund Activity: Q3 2021 in Review
262 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2021, worth a combined $4.11B — down 4.3% from $4.3B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CNMD positions and 26 closed out — a net gain of 11 holders — while 99 added to existing stakes and 77 trimmed.
The largest buyer was CI Investments Inc, adding an estimated $27.8M. The largest seller was Davidson Kempner Capital Management, cutting an estimated $34.8M.
- 262 institutional investors held CONMED (CNMD) as of Q3 2021, up from 252 in Q2 2021.
- Funds reported $4.11B of CONMED stock for Q3 2021, down 4.3% quarter-over-quarter.
- 37 funds opened new CONMED positions in Q3 2021 and 26 closed out, a net change of +11 holders.
- The largest CONMED buyer in Q3 2021 was CI Investments Inc, an estimated $27.8M added.
- The largest CONMED seller in Q3 2021 was Davidson Kempner Capital Management, an estimated $34.8M sold.
Based on aggregated 13F filings for Q3 2021.